Using Ozempic for weight loss in someone without diabetes is "off-licence" and not currently sanctioned by the HSE
The MAPK signalling pathway, which includes ERK1/2, c-Jun N-terminal kinase, and p38 MAPK, is also a central mediator in the development of obesity [61,62,63,64]
Beyond aiding fertility, these medications improve overall hormonal health and address symptoms like acne and excessive hair growth
Shanice C
Nrf2 binds to antioxidant response elements (ARE) and oxidative stress-related proteins (including GSH, HO-1, and oxidoreductase I), and then scavenges cytotoxic electrophiles together with ROS (218)
The growth in the forecast period can be attributed to expanding obesity management indications, increasing demand for effective weight loss drugs, growing awareness of cardiometabolic benefits, pipeline expansion of next-generation glp-1 therapies, rising healthcare focus on preventive metabolic care